Легочная гипертензия - новый аспект кардиоренального синдрома
Аннотация
Об авторах
Татьяна Евгеньевна РуденкоРоссия
Ирина Михайловна Кутырина
Россия
Мария Павловна Васильева
Россия
Нина Иосифовна Соломахина
Россия
Список литературы
1. Чазова И.Е., Авдеев С.Н., Царева Н.А. и др. Клинические рекомендации по диагностике и лечению легочной гипертензии. Тер арх 2014; 9: 4-23
2. Galie N., Hoeper M.M., Humbert M. et al. Guidelines for the diagnosis and treatment of pulmonary hypertension: the task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS)., endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J 2009; 30: 2493-2537.doi:10.1093/eurheartj/ehp297
3. Simonneau G., Gatzoulis M.A., Adatia I et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 2013; 62: D34-D41. doi.org/10.1016/j.jacc.2013.10.029
4. Fabbian F., Cantelli S., Molino C. et al. Pulmonary hypertension in dialysis patients: a cross-sectional Italian study. Int J Nephrol 2010; 2011: 283475. doi.org/10.4061/2011/
5. Yigla M., Fruchter O., Aharonson D. et al. Pulmonary hypertension is an independent predictor of mortality in hemodialysis patients. Kidney Int 2009; 75: 969-975 doi: 10.1038/ki.2009.10.
6. Ramasubbu K., Deswal A., Herdejurgen C. et al. A prospec tive echocardiographic evaluation of pulmonary hypertension in chronic hemodialysis patients in the United States: prevalence and clinical significance. Int J Gen Med 2010; 3: 279-286. doi: 10.2147/IJGM.S12946
7. Unal A., Tasdemir K., Oymak S et al. The long-term effects of arteriovenous fistula creation on the development of pulmonary hypertension in hemodialysis patients. Hemodial Int 2010; 14: 398-402. DOI: 10.1111/j.1542-4758.2010.00478.x
8. Agarwal R. Prevalence., determinants and prognosis of pulmonary hypertension among hemodialysis patients. Nephrol Dial Transpl 2012; 27: 3908-3914 doi: 10.1093/ndt/gfr661
9. Бородулина E.O., Карпунин С.А., Шутов А.М. Легочная гипертензия у больных на гемодиализе. Клин нефрол 2015; (1):19-22
10. Unal A., Sipahioglu M., Oguz F. et al. Pulmonary hypertension in peritoneal dialysis patients: prevalence and risk factors. Perit Dial Int 2009; 29: 191-198
11. Kumbar L., Fein P.A., Rafiq M.A. et al. Pulmonary hypertension in peritoneal dialysis patients. Adv Perit Dial 2007; 23: 127-131
12. Yang Q.M., Bao X.R. Pulmonary hypertension in patients with stage 1-3 chronic kidney disease. Genetics and molecular research 2014; 13 (3): 5695-5703 DOI dx.doi.org/10.4238/2014. July.25.25
13. Li Z., Liang X., Liu S. et al. Pulmonary hypertension: epidemiology in different CKD stages and its association with cardiovascular morbidity. PLOS ONE 2014; 9 (12): e114392. DOI: 10.1371/ journal.pone.0114392
14. Bolignano D., Rastelli S., Agarwal R. et al. Pulmonary Hypertension in CKD. Am J Kidney dis 2013; 61(4): 612-622. http:// dx.doi.org/10.1053/j.ajkd.2012.07.029
15. Моисеев B.C., Мухин Н.А., Смирнов А.В. и др. Сердечно-сосудистый риск и хроническая болезнь почек: стратегии кардио-нефропротекции. Росс кардиол журн 2014; 8 (112): 7-37
16. Kawar B., Ellam T., Jackson C., Kiely D. Pulmonary Hypertension in Renal Disease: Epidemiology., Potential Mechanisms and Implications. Am J Nephrol 2013; 37: 281-290. DOI: 10.1159/000348804
17. Zoccali C. Pulmonary hypertension in dialysis patients: a prevalent., risky but still uncharacterized disorder. Nephrol Dial Transpl 2012; 27: 3674-3677. doi: 10.1093/ndt/gfs425
18. Havlucu Y., Kursat S., Ekmekci C. et al. Pulmonary hypertension in patients with chronic renal failure. Respiration 2007; 74: 503-510. DOI: 10.1159/000102953
19. Kim S.C., Chang H.J., Kim M.G. et al. Relationship between pulmonary hypertension., peripheral vascular calcification., and major cardiovascular events in dialysis patients. Kidney Res Clin Pract 2015; 34: 28-34. doi:10.1016/j.krcp.2015.01.003
20. Nakhoul F., Yigla M., Gilman R. et al. The pathogenesis of pulmonary hypertension in haemodialysis patients via arterio-venous access. Nephrol Dial Transpl 2005; 20: 1686-1692. doi:10.1093/ ndt/gfh840
21. Yu T.M., Chen Y.H., Hsu J.Y. et el. Systemic inflammation is associated with pulmonary hypertension in patients undergoing haemodialysis. Nephrol Dial Transpl 2009; 24: 1946-1951. doi: 10.1093/ndt/gfn751
22. Yigla M., Banderski R., Azzam Z.S., et al. Arterio-venous access in end-stage renal disease patients and pulmonary hypertension. Ther Adv Respir Dis 2008; 2: 49-53 doi: 10.1177/ 1753465808089456
23. Kiykim A.A., Horoz M., Ozcan T. et al. Pulmonary hypertension in haemodialysis patients without arteriovenous fistula: the effect of dialyzer composition. Ren Fail2010; 23: 1148-1152. DO I: 10.3109/0886022X.2010.516854
24. Zoccali C. Endothelial dysfunction and the kidney: emerging risk factors for renal insufficiency and cardiovascular outcomes in essential hypertension. J Am Soc Nephrol 2006; 17(4 Suppl 2):S61-63. doi:10.1681/ASN.2005121344
25. Смирнов А.В., Петрищев Н.Н., Мнускина М.М. и др. Дисфункция эндотелия и апоптоз на ранних стадиях хронической болезни почек. Тер арх 2012; 84 (6): 9-15
26. Эмануэль В.Л., Мнускина М.М., Смирнов А.В. и др. Аннексин-5 - биохимический маркер ранних сосудистых нарушений при хронической болезни почек. Клин лаб диагн 2013; (4): 9-10
27. Abdelwhab S., Elshinnawy S. Pulmonary hypertension in chronic renal failure patients. Am J Nephrol 2008; 28: 990-997. DOI:10.1159/000146076
28. Dorfmuller P., Zarka V., Durand-Gasselin I. et al. Chemokine RANTES in severe pulmonary arterial hypertension. Am J Respir Crit Care Med 2002;165:534-539. doi: 10.1164/ ajrccm.165.4.2012112
29. Joppa P., Petrasova D., Stancak B. et al. Systemic inflammation in patients with COPD and pulmonary hypertension. Chest 2006;130:326-333. DOI 10.1378/chest.130.2.326
30. Carrero J.J., Stenvinkel Р. Persistent inflammation as a catalyst for other risk factors in chronic kidney disease: a hypothesis proposal. Clin J Am Soc Nephrol 2009; 4: S49-S55. doi: 10.2215/ CJN.02720409
31. Нефрология. Национальное руководство, ред. Н.А. Мухин. ГЭОТАР-Медия, М., 2009. 720 с.
32. Akmal M., Barndt R.R., Ansari A.N. et al. Excess PTH in CRF induces pulmonary calcification, pulmonary hypertension and right ventricular hypertrophy. Kidney Int 1995; 47: 158-163. doi:10.1038/ki.1995.18
33. Issa N., Krowka M.J., Griffin M.D. et al. Pulmonary hypertension is associated with reduced patient survival after kidney transplantation. Transplantation 2008; 86: 1384-1388. DOI: 10.1097/ TP 0b013e318188d640
34. Zlotnick D.M., Axelrod D.A., Chobanian M.C. at al. Non-invasive detection of pulmonary hypertension prior to renal transplantation is a predictor of increased risk for early graft dysfunction. Nephrol Dial Transpl 2010; 25: 3090-3096. doi: 10.1093/ndt/gfq141
Рецензия
Для цитирования:
Руденко Т.Е., Кутырина И.М., Васильева М.П., Соломахина Н.И. Легочная гипертензия - новый аспект кардиоренального синдрома. Нефрология. 2016;20(2):48-52.
For citation:
Kutyrina I.M., Rudenko T.E., Vasilyeva M.P., Solomakhina N.I. Pulmonary Hypertension - a new aspect of cardiorenal syndrome. Nephrology (Saint-Petersburg). 2016;20(2):48-52. (In Russ.)